Cancer NetworkOriginal article
<![CDATA[FDA Grants OncoSil Humanitarian Device Exemption in Distal Cholangiocarcinoma]]>
RegulatoryapprovedOncoSilPositive
AI Analysis
Summary
The FDA granted OncoSil Medical a humanitarian device exemption for its intratumoral radiation device to treat unresectable, non-metastatic distal cholangiocarcinoma. This regulatory approval enables commercialization of the device for this orphan indication.
Outcome Details
Humanitarian Device Exemption granted
Importance:7/10
Sentiment:
0.80
FDA approvalmedical devicehumanitarian exemptioncholangiocarcinomaintratumoral radiation
Related Companies
Read the original article
Published by Cancer Network on August 17, 2026 7:21 PM